The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
C5a is rapidly desarginated by serum carboxypeptidase N to the less potent derivate C5a desArg, the first stage in deactivation of anaphylatoxin activity. The C5a desArg form has a different spectrum of bioactivity to intact C5a.
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
ReconstitutionReconstitute the vial by injection of 0.5 ml distilled or de-ionised water. Store stock solution after reconstitution in aliquots at -20°C. Repeated freeze and thaw cycles cause loss of activity.
For dilutions use protein stabilized phosphate buffered saline, pH 7.4.
Anaphylatoxin C5a analog
Complement C5 precursor
Complement component 5
Complement component C5a
RelevanceC5 is involved in the activation of the lytic pathway within the complement system, which is an important factor in innate immunity.
References for Recombinant Human C5a / C5a des Arg protein (ab91017)
has not yet been referenced specifically in any publications.
Publishing research using ab91017? Please let us know so that we can cite the reference in this datasheet.
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"